Skip to main content
Caplight Logo









Centese

Centese

Private
Omaha, NebraskaHealthcare & Life Scienceshttps://www.centese.com/

Last Round

Series B

Extension

Aug 3, 2025

Total Funding Raised

$18.15M

Company Overview

Centese is a healthtech company that develops an advanced post-operative surgical drainage system to address complications in open-heart or open-lung surgery.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Healthcare Analytics, Health IoT

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

surgical drainage systemchest tubecardiothoracic surgeryactive clearancemedical devicepost-operative caredrainage monitoringthoracic drainagesmart chest drainhospital equipmentsurgical disposablesdigital chest drainage

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Centese Comparables

Compare Centese with similar companies based on industry and business-model similarity.

Centese comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
ClearFlow, Inc.
91%
Teleflex Incorporated
79%
Medela
76%

Centese Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series B ExtensionAug 3, 2025
Series BNov 21, 2023
GrantFeb 22, 2016

Key People

Founding team and executive leadership

Evan Luxon

Co-Founder CEO

Founding Team

Centese Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Nov 21, 2023

    $15M round led by Medical Technology Venture Partners

Centese Filings

Explore SEC and related filing metadata, where available.

Centese filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Centese's valuation, stock price, and market status.

Is Centese a public or private company?

Centese is a private company.

What is the current stock price of Centese?

Centese is a private company with no public stock price. No recent secondary market data is available.

How much is Centese worth (valuation)?

Valuation information for Centese is not publicly available.

Can I buy Centese stock?

Centese shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Centese's last funding round?

Centese's most recent funding round was Series B Extension on August 3, 2025.

Who are the main investors in Centese?

Key investors in Centese include Medical Technology Venture Partners.

Will Centese IPO soon?

No public IPO plans have been announced for Centese.

How can I track Centese secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Centese's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersOmaha, Nebraska
Employee Range14
Year Founded2016
Last FundingAug 3, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?